Annex 1. Vote on questions of the modules of the consensus (Delphi methodology).

Module
No PREVENTION OF Candida spp. IFDs 9 9.0 9 9/9 9/9 100 Annex 2. Score of guidelines found in the bibliographical search by AGREE II methodology 38, 40, 42, 46, 70, 72, 108, 178, [388] [389] [390] [391] [392] . Characteristics of colonies per species after incubation in CHROMagar Candida® medium, at 37 °C, for two days
MODULE
Species
Color and morphology
Candida albicans
Green.
Candida tropicalis
Dark blue to grey blue (with pink halo in agar).
Candida krusei
Pale pink to purple (intense tone with pale edges) and a dry texture. Sensititre™ YeastOne™ (Trek Dg. System) is a colorimetric dilution method based on the CLSI microdilution method.
• It incorporates Alamar blue, an oxidoreductase dye that turns red when there is growth and remains blue when there is no growth. • Good reproducibility. One advantage is a more objective reading because turbidity should not be read but only the change in color.
• Limitations º Color change may be difficult to appreciate in some isolates. º Paradoxical effect (growth in concentrations above MIC) is common with itraconazole and echinocandins.
Neo-Sensitabs™ (Rosco Diagnostic) and SensiDisks (Bio-Rad), are tablets containing the antifungal agent in crystallized form. Its main advantage is the stability of the tablets (up to 4 years at 4-8°C).
• They are an inexpensive, reproducible and easy to perform resource in routine laboratory tests. 
C. africana
Not described Closely related to C. albicans. This species exhibits an intrinsic susceptibility pattern. It is probably less pathogenic than C. albicans and were found almost exclusively in female urinary tract samples.
C. auris
Not described Related to C. haemulonii. FCZ MIC is higher than that of C. albicans. Multi-resistant species and very durable in the environment. Resistant to the usual hospital disinfectants.
C. bracarensis
Not described Closely related to C. glabrata. Its susceptibility pattern is similar to that of C. glabrata (high azole MIC compared with that of C. albicans).
C. ciferrii Trichomonascus ciferrii
Uncertain clinical significance. Inherent resistance to several antifungal agents.
C. dubliniensis
Not described Closely related to C. albicans. With an intrinsic susceptibility pattern similar to that of the abovementioned species; however, it has the potential for acquired resistance.
C. fabianii Cyberlindnera fabianii
Uncertain clinical significance. FCZ MIC is higher than that of C. albicans.
C. famata
Debaromyces hansenii
This species is an uncommon fungemia-causing agent. Recent data question whether this species is a human pathogen (it does not grow at 37°C and there are no cases confirmed by sequencing analysis).
C. guilliermondii Meyerozyma guilliermondii
Closely related to C. fermentati and C. palmioleophila. Echinocandin and azole MIC is high C. haemulonii (including C. duobushaemulonii)
Not described
May be a human pathogen associated with surface infections and central venous catheter fungemia, in particular in Brazil, the Caribbean and some regions in Asia.
Azole and AB MIC is high. Related to C. auris.
C. hellenica Zygoascus meyerae
There have been reports of fungemia and respiratory infections caused by this species. Reduced susceptibility to FCZ, ITZ and CAS. It is susceptible to VCZ.
C. inconspicua
Not described Closely related to C. norvegensis. Its susceptibility pattern is similar to that of C. krusei (intrinsically susceptible to FCZ).
C. intermedia Not described
It is an oropharingeal colonization agent associated with bloodstream infections and peritonitis.
It is susceptible to all antifungal agents except for 5FC.
C. kefyr Kluyveromyces marxianus
No inherent resistance to antifungal agents has been described.
C. lipolytica Yarrowia lipolytica
C. lusitaniae
Clavispora lusitaniae AB tends to be inefficient (even with MIC ≤1 mg/L).
C. metapsilosis
Not described Closely related to C. parapsilosis. Its susceptibility pattern is similar to that of the abovementioned species (high echinocandins MIC).
C. nivariensis
Not described Closely related to C. glabrata. Its susceptibility pattern is similar to that of C. glabrata (reduced susceptibility to azole).
C. norvegensis Pichia norvegensis
Closely related to C. inconspicua. Its susceptibility pattern is similar to that of C. krusei (intrinsically susceptible to FCZ).
C. orthopsilosis
C. palmioleophila Not described
Phenotypically related to C. guilliermondii. Azole MIC is high but echinocandin MIC is low (unlike C. guilliermondii).
C. pelliculosa
Wickerhamomyces anomalus (formerly known as Pichia anomala, Hansenula anomala)
FCZ MIC is higher than that of C. albicans.
C. pulcherrima
Pichia kudriavzevii (formerly known as Metschnikowia pulcherrima)
Its clinical significance is uncertain.
C. rugosa
Not described FCZ MIC is higher than that of C. albicans.
C. subhashii Not described
C. viswanathii Not described
C. zeylanoides Not described
Its clinical significance is uncertain. High susceptibility to most of the species; it is not reliable for the detection of certain species such as C. parapsilosis o C.
guilliermondii.
PPV 17-94%; NPV 89-94%.
Its high NPV makes it a good alternative disease exclusion test, which would avoid unnecessary antifungal treatment.
Interpretation of results:
A negative MN Ag. result does not exclude the diagnosis of IC, mannanemia is a short-term condition. It yields results 7 days earlier than detection in blood cultures.
Its diagnostic usefulness varies and depends on the studied population of patients.
PPV 22-63%; NPV 77-96%.
It is considered particularly useful in patients with intraabdominal infections, in whom culture sensitivity is reduced.
Optimal results are obtained when two consecutive tests are positive.
One positive result does not allow the identification of the species causing the infection.
There is a correlation between a positive test and proven IC. Annex 12. Available molecular and proteomic biomarkers for the diagnosis of candidemia/IC 37, 39, 55, 66, 68 . 37, 39, 55, 66, 68 . DL: Detection Limit; S: Sensitivity; Sp: Specificity; (%): Percentage; NAAT: Nucleic acid amplification test; PNA FISH: Fluorescent in situ hybridization using peptide nucleic acid; MALDI-TOF MS: Matrix assisted laser desorption ionization time-of-flight; PCR/ESI-MS: PCR + mass spectrometry + electrospray ionization. Adapted from: Lewis RE; Bellmann R et al 65, 124 .
CAGTA
Candida albicans
PAE: Post-antifungal effect.
